Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's just catching up to yesterdays action. The prints are much slower than TWD.
I wish I was tracking this, what is the longest the shop has been "out of stock" of any particular strain at a time? Just simple observation makes me think it hasn't been longer than 48 hours. I wish I knew for sure.
Overvalued in what way? By what measure?
By the measure of market sentiment? Sure.
By the measure of the company? Absolutely not. Having two licenses and two operational facilities. Sales. A brand. If anything it's undervalued.
Will Tweed one say be forced to release sub patient numbers? Maybe.
Do I care they don't release that? No. It doesn't bother me. What matters to me is seeing the company move forward. This is an emerging market.
Using the example of a company YOU yourself are invested in and ironically there has been bashing from people of that board to this board lately. Not sure why.
F!@X has double the market cap of Tweed yet has zero licenses and is bleeding money with no sales. That's not even to mention the mess of a share structure that it is. The market at this time values it higher. I won't speculate as to why and I won't comment on my opinions of the company but using PPS and market cap as evidence, again, is not evidence.
Not agreeing with the explanation given by the CEO of a company is not evidence to the contrary. "This is the answer. take it or leave it".
Show me EVIDENCE that not providing patient numbers is nefarious. I offered you evidence of my position. Show me yours. =)
That's a good point, I did not think of that.
My professional life experience, one specifically I worked at from its infancy all the way to being acquired by one of the largest companies in the world and becoming a household name. I can confidently say this would make sense.
See, right there I know you're not serious about an honest debate/discussion. You use PPS are your evidence to support your position that Tweed has low numbers. That's not evidence. You could then make the same argument of EVERY MJ stock and say ALL of them are bad companies.
The entire sector has dropped 50+ percent this year. That doesn't mean the sector is dead or bad all it means is the sector is bearish.
Please read my post #9892 for my understanding of the subject along with evidence to support my claims/opinions/statements.
Here are all the reasons I can come up this in my brain, I will add any evidence that I feel relevant to my reasons.
1) AS THE COMPANY STATED: Not disclosing the patient numbers helps ensure people buy more, more often.
James West: Hmm. That’s interesting Bruce. So tell me, how many clients did you have in April and how many do you have now?
Bruce Linton: It’s really bad not to answer questions, but let me give you what I think is a good non-answer. When one person asked me about this, I said ‘What I think you guys really care about is how many hot dogs were eaten. Not who ate the hot dogs.’ And so, if we had Joey Chestnut, the world champion hot dog eater as our client, he might eat a lot more than the average person. So we haven’t been disclosing the number of patients. What we have been disclosing is that we found in the early stages, when there was scarcity, and people didn’t know when we’d have more supply, their individual buying patterns we don’t think were predictive, but they were buying as much as they might have been allowed to. And so we’re going to continue to go out not disclosing the number of individual hot dog eaters if you will, but rather we’re going to disclose the value and the volume and the division between sources of production. And I think that combination, people will be able to see same store visits, quarter-over-quarter, how much more did you move?
And so it was an early choice, because as soon as you disclose patients, you get an entirely different matrix. And I’m not sure that’s a helpful thing.
So we’ve been selling out, and we’ve been selling out quickly, and now we’re finally not selling out, and we’re being able to put more people onto our buyers list, and that’s kind of the story line.
Response from Tweed Investor relations:
My Email this morning:
Good morning,
I have another question. How does the license for each facility work? I was under the impression that licenses are per facility and include a max production allowance. Is this accurate?
May I get what are the maximum allowances for each facility in order to cross reference the information I have.
Thank you kindly.
Hi XXXXXXXXXX:
Thanks for reaching out - I was actually just about to write you. I noticed in the forum you discussed a strain album, and I wanted to let you know I will soon be working on a macro series of our varieties. This may be of interest to you and others in the forum.
Your information is correct, however I will have to find the exact numbers for you. Will circle back shortly.
Have a great day,
XXXXXXXXXX
Marketing Manager
If you're going to go to a board simply to 'bash', please know the difference between 'through' and "threw".
Furthermore if you believe that the resignation of Chuck Rifici is as you say "check mate" then congratulations, you have zero reason to be on this board. Please move on.
Thank you for that post, it's an excellent summary of our current position.
I think this evening I'll work on a section or improve on the strains section so that it also shows images of the strains themselves. That looks too good to not put front and center.
Your argument is not without merit but it's the same argument that can be made of any other producer. Including one you are currently invested in that starts with an F and ends with an X.
My counter point is, as previously stated, Tweed is eyeing international expansion. They have the cash, if they prefer they have offers from Canadian banks for loans, and the experience in doing so. The next few years is going to be interesting and I suspect as other countries fall in line with the winds of change the Tweed brand will be there.
There is also the 2015 election which if Liberals win, and polls currently show that might be the case, recreational MJ will likely be in play.
Tweed is projected to grow 22046.22 lbs by end of 2015 . This is equated to about 100 million of annual revenue in just MMJ.
There are no definitive plans to grow more at this time.
CEO has expressed Tweed is looking to expand internationally.
Please read the Q2 sticky and associated links to get a clear synopsis of short term expectations.
Nothing is definitive as there are two legal challenges currently in Canadian courts.
1. Personal growers right to grow. -
*I'm of the opinion that personal growers will not create an impact to the LPs. My reasoning is historical precedence of Alcohol products.
2. Edibles/oils/ext ability to be sold through licensed producers. -
*Tweed current margin is approx. 70%. Should edibles/oils/ext become part of the bottom line we should see those margins go up along with additional revenue streams.
Early 2015 to Mid 2015 is the expected closure of these cases.
Thank you for that great read. If we see more articles like these I suspect we will be getting prepped for a bull run come Nov area.
Full article for the link impaired.
When the tour bus finishes the climb up the lush mountainside and comes to a stop at Nine Mile, Jamaica, the local men are ready. There is already a lineup of tourists at a stone wall outside the Bob Marley memorial site, and from a hole in the wall the Jamaican men conduct their business, selling $15 cigar-sized marijuana joints and large portions of pot-infused cake. Inside the Bob Marley compound, where the tour will include the Rastafarian reggae superstar’s childhood home, the tourists will be able to enjoy their purchases legally, and soon many of them will be smoking on the verandah of an open-air bar.
In just another two months, Jamaica will announce decriminalization of small amounts of ganja for personal use, but on this day the Bob Marley site is the only place on the Caribbean island where smoking marijuana is legal.
It is April, and change is in the wind in Jamaica, in Canada and elsewhere around the globe.
As the end of the fiscal first quarter draws near, the state of Colorado is counting $11 million in tax revenue from marijuana sales in a retail experiment that began in January. Under a plan proposed by state Governor John Hickenlooper, the tax revenue is marked for youth prevention services, substance abuse treatment and public health. The governor estimated sales in all marijuana stores would approach $1 billion for the fiscal year. While revenue in state coffers grew, crime rates dropped.
Canadian Liberal leader Justin Trudeau had already advocated studying best practices from Colorado. For some, a Canadian legal marijuana program is a question of when, not if.
“Within five years,” predicted former B.C. solicitor general and former police chief Kash Heed, speaking to CBC Radio in May. Now working as a consultant to medical marijuana companies, he added: “And that is a positive thing, because we can now take taxation dollars and put it back into programs such as prevention, education and health care that is so sadly needed here in Canada.”
To get clear perspective on the global marijuana movement and the benefits and pitfalls in the choices facing policy makers, medical marijuana and its recreational use both factor in the equation. They are not the same, but there is just one industry: cannabis. Colorado and Washington’s legalization programs underscore the industry is lucrative, and suggest the astuteness of a government-regulated retail industry replacing an unregulated criminal marketplace.
In Canada, the marijuana debate is stoked by the federal election coming in October, 2015.
“The fact of the matter is our current approach on marijuana -- the prohibition that (prime minister) Stephen Harper continues to defend -- is failing in two primary ways,” Mr. Trudeau told the Canadian Press. “The first one is it is not protecting our kids from the negative impacts of marijuana on the developing brain. Secondly, we are funnelling millions upon millions of dollars each year into organized crime and criminal gangs. We do not need to be funding those organizations.”
A new medical marijuana industry was launched when Health Canada changed its regulations April 1, requiring patients with doctors’ notes to obtain their pot directly from licensed producers. Pundits said the Conservative government was trying to distance itself from marijuana, but what entrepreneurs saw was ground-floor opportunity. The department was flooded with hundreds of applications from would-be growers, who will have a lucrative market if Canada follows the U.S. lead on recreational sales. But there is already a substantial market unfolding; Ottawa projected the medical marijuana market will hit $1.3 billion annually by 2024, with some 450,000 registered users. By August, however, grow licences had been granted to just 13 companies.
The island of Jamaica, cited by the United States as its largest Caribbean supplier of illegal pot, saw possibilities in legitimate export as the global marijuana landscape shifted. In the same month that Canada’s revamped medical marijuana program got underway, the Jamaica Ganja Future Growers and Producers Association held its inaugural meeting. Some months earlier, in late 2013, Dr. Henry Lowe, a prominent and internationally-recognized Jamaican scientist, had already launched the island’s first medical marijuana firm.
There is a sense of urgency being cultivated along with the ganja crops. At the first Jamaica Cannabis Conference at the University of West Indies in May, the theme was, “Wake Up Jamaica, Our Opportunities Are Slipping Away.” The roster of international speakers, local media reported, included participants from Israel, China, the United States and Canada. In early June, the Jamaican government announced marijuana decriminalization.
On an island with wide disparity between the well-off and those living in poverty, tour guides gesture to the better homes on the hillsides, commenting that drug dealers live among the wealthiest. It’s easy to envision improvements to the economy, the crime rates and the lives of the farmers with Jamaica’s involvement in a legitimate marijuana industry.
The groundswell of global change is just beginning.
“It’s a young industry,” notes Fonda Betts, director of Greenleaf Medical Clinic and CEO of MedicalMarijuana.ca in British Columbia. Her clinic, founded in 2011, assesses patients for their eligibility into Health Canada’s medical marijuana program, and provides consultations with a cannabis-knowledgeable physician where appropriate. Clients are required to provide proper documentation of their medical condition. “It’s a great industry; it’s wonderful when we can give patients relief. It’s doing great things out there ... I’ve seen patients where we’ve given them their life back.”
Her business plan includes future cannabis clinical trials with the University of British Columbia and applying to Health Canada to be a licensed marijuana producer. But even now, 3,500 adult patients are referred to her clinic annually, including the elderly. Toronto-based MedCannAccess opened a similar clinic, the MedCannAccess Solution Centre, in Hamilton in late August.
The market, in its infancy since Health Canada changed its regulations, has even more potential since the British Columbia Appeal Court ruled in August it’s unconstitutional for Health Canada to outlaw patient use of marijuana-based products such as cookies, cakes, oils, creams and candy bars. Parliament was given one year to craft regulations to allow medicinal marijuana patients to use products made from cannabis extract.
A U.S. pizza chain, meanwhile, announced it was working on marijuana-infused sauces, for distribution in states with recreational and medical marijuana programs.
Investors could get hungry. Ontario-based marijuana company Tweed was the first Canadian company out of the gate on the Toronto Stock Exchange, and other companies were poised to follow. South of the border, Wall Street commodities expert Steve Janjic launched Amercanex, an electronic marketplace exchange for the cannabis industry, where company inventories can be bought, sold and traded on a Wall Street model.
“We will soon hit the tipping point at which state after state will legalize cannabis like falling dominos,” he said in a press release.
If potential tax revenue and economic growth aren’t enough to get Canadian politicians’ attention, they will find it increasingly difficult to defend the status quo. The majority of Canadians, according to the Harper government’s own opinion poll, favour either legalization or decriminalization. The publication of the poll results in late July and the timing of Justice Minister Peter MacKay’s comments on softening marijuana laws were duly noted.
But there’s more at stake than votes, money and harsh penalties against marijuana smokers. The country needs to actively facilitate more medical research, exploring evidence that cannabis provides relief to people suffering chronic pain, seizures, cancer and other conditions.
“From a physician’s standpoint, it’s very difficult,” says Ms. Betts, noting the lack of a drug identification number for cannabis means doctors can’t write out a traditional prescription, and have no clear guidelines on patient dosages, medicinal uses or risks.
To get a DIN on a drug, Health Canada requires that clinical trials be carried out by physician-led research teams. The department must approve the trial first, and then agree with any conclusions that benefits outweigh risks, before a drug gets a DIN. Without the eight-digit number, a drug product can’t be sold in Canada.
On its website, Health Canada notes that the sponsors of clinical trials, those who want to test a drug in the first place, are most often drug companies, hospitals, universities and researchers.
At the Canadian Medical Association annual general meeting in Ottawa in August, incoming president Dr. Chris Simpson told reporters the CMA has a long-standing policy supporting the decriminalization of pot “because we don’t see the value of turning people who smoke marijuana into criminals.” On medical marijuana, he added: “We are very sympathetic to the number of Canadians who tell us that they derive relief from marijuana. So we stand in solidarity with the patients. But our position is very clear: The evidence is insufficient to support its use as medicine.”
The CMA called for “comprehensive regulatory standards” to guide doctors in prescribing marijuana.
Research is being done industry wide, says Ms. Betts, that will ultimately aid doctors when cannabis is granted a DIN. “There’s definitely research going on behind the scenes ... there’s a lot going on in the world.”
Saskatchewan-based Prairie Plant Systems, until recently Health Canada’s sole supplier of medical marijuana, has registered the first clinical trial with the government under its revamped legislation. The trial will measure the effects of vapourized cannabis on patients with osteoarthritis of the knee against other patients who receive a placebo.
The study will “provide prescribing physicians with the clinical data they are looking for regarding dosing,” said Brent Zettl, president and CEO of the company, in a Huffington Post article. Prairie Plant Systems is the parent company of CanniMed Ltd., one of the first 13 companies licensed by Health Canada under the new medical marijuana rules.
There will be a lot for medical researchers to collectively bring forth. Smoking marijuana, for example, isn’t the only option. Cannabis can be administered in oils, pills and vapourizers, and marijuana can be grown so that its medicinal cannabidiol is increased, while the high-producing THC content is lowered or eliminated. The growing technique means a strain called “Charlotte’s Web” can be given to children, in treatment for epilepsy. Cannabis oil for children is not available in Canada due to lack of clinical trials. But some American families have packed up and moved to Colorado in an attempt to find help for their children.
Dr. Sanjay Gupta, an American neurosurgeon and chief medical correspondent for CNN, explored the potential of cannabis treatments and the “politics of pot” in his documentary ‘Weed 2’, broadcast in March. The doctor, who in 2009 penned a Time magazine article, ‘Why I would vote no on pot’, later changed his views and apologized to readers, saying he’d uncovered “stunning” evidence by digging deeper into “remarkable research” being done in smaller labs in other countries.
“I have sat in labs and personally analyzed the molecules in marijuana that have such potential but are also a source of intense controversy,” he writes on the CNN website. “I have seen those molecules turned into medicine that has quelled epilepsy in a child and pain in a grown adult. I’ve seen it help a woman at the peak of her life to overcome the ravages of multiple sclerosis.
“I am more convinced than ever that it is irresponsible to not provide the best care we can, care that often may involve marijuana.”
A pharmaceutical DIN for cannabis would also mean coverage under medical plans, easing the costs for patients.
Durham Region licensed medical marijuana user Al, who didn’t want his last name used because of the “stigma” he feels from the community, says traditional medication didn’t help with the epileptic seizures he suffered since childhood. Smoking marijuana means he has no seizures at all, he says, but the cost of $7.50 per gram plus tax and shipping means he’s paying $600 a month for what he considers medicine.
“(Justice Minister) Peter MacKay says he’s going to ticket people,” he says. “Well I’m getting ticketed every day. I’m not interested in getting blitzed. I want to be able to do my job. I want to be able to sleep.”
Some patients who can’t afford cannabis are forced to turn back to addictive opioid-based medications, Ms. Betts says.
Currently, Health Canada wants to prohibit patients from growing their own weed, but a federal court injunction was granted until further constitutional arguments can be heard. The government pointed out, not unwisely, that home grow-ops lead to burglaries and crime.
Moreover, licensed growers can ensure quality control. As savvy entrepreneurs and investors have no doubt deduced, they’ll be in a position to respond swiftly to market demand when or if Canada introduces a recreational marijuana program.
But the most logical reason for Canada to adopt legal marijuana sales is to take the market away from organized crime, making the drug less accessible to children on streets and playgrounds. In Uruguay, the government this year moved to selling marijuana for $1 a gram, to put the criminals out of business.
Macleans magazine reported in 2013 that Canadian children and youth are the heaviest users of cannabis in the developed world, citing a report from UNICEF. The magazine noted that Germany, Portugal, Belgium, Italy and the Netherlands, where pot use has been decriminalized, legalized or liberalized, all have rates of child cannabis use that range from one-third to more than one-half lower than in Canada.
Children are vulnerable because their brains are not fully developed. The American National Institute on Drug Abuse cites studies that show people who began smoking marijuana heavily in their teens lost an average of eight points in IQ between age 13 and age 38. Those who started smoking marijuana in adulthood did not show significant IQ declines.
Macleans put the health and social costs of cannabis, tobacco and alcohol in perspective for readers. It cited Health Canada data charted by Gerald Thomas, an analyst with the Centre for Addictions Research of B.C., and Chris Davis, an analyst with the Canadian Centre on Substance Abuse. They found tobacco-related health costs are more than $800 per user; alcohol-related health costs were $165 per user; and cannabis-related health costs were $20 per user. Enforcement costs added $153 per drinker and $328 for a cannabis user. “In other words, 94 per cent of the cost to society of cannabis comes from keeping it illegal,” Vancouver bureau chief Ken MacQueen wrote.
Ms. Betts says she’s “all about the medical side” of marijuana and hesitates when asked if she believes Canada should allow its legal recreational sale. “In my heart of hearts, yes,” she says, after a pause. “It’s better than alcohol, 100 per cent.”
Early morning bounce on what seems to be normal volume. 1/3 of the buys from U.S. symbol TWMJF.
Demand is outpacing supply in the industry
http://www.news1130.com/2014/10/02/hundreds-of-companies-still-waiting-for-medicinal-pot-growing-licences/
Hundreds of companies still waiting for medicinal pot-growing licences
Only 13 business out of 300 have been granted approval
VANCOUVER (NEWS1130) – It’s been six months since new federal laws kicked in requiring all medicinal marijuana to be grown in commercial facilities.
However, Health Canada has approved only a fraction of the businesses which have applied for licences.
Thirteen companies are listed as licenced producers on Health Canada’s website.
Herb Bell with Canadian Medical Cannabis Partners points out 300 companies have applied.
“Health Canada is lacking. They’ve completely dropped the ball. They are understaffed and overwhelmed. They are being sued. They don’t want to move too quickly. This is like a trial period for them,” he says.
A single company, he estimates, can only supply about 3,000 patients, so demand is outstripping supply.
“In Vancouver, doctors don’t even bother going the federal route. It takes too long. They’ll just give you a card for one of the medical dispensaries in the area that operate in a legally grey area.”
Canada’s medicinal marijuana laws are the subject of two court cases.
People wanting to continue growing their own medicinal pot in accordance with laws before April 1 are challenging the new legislation, and have been granted an injunction to continue their home-grown operations.
The Supreme Court of Canada is also being asked to consider whether laws should be revised to allow people to ingest, rather than strictly smoke, cannabis-laced products for health reasons.
The best thing we can do is not feed them.
It's good to defend your thesis on a position but do so as professionally as possible. Don't lower yourself and let the emotion drive you. Be Vulcan.
Mods will do what they can to stave off the attacks to keep a clean and secure board.
Keep the information factual and/or constructive and I will continue to keep clean concise information on the landing page and stickies.
Times like these bring out the worst. I am still waiting on a reply from investor relations to my questions from Thurday and Friday. Once I receive a reply I will post it.
I make it a point to make it easy for everyone to have the company contact info so they themselves can also contact them if their are concerns they have.
See you guys Monday. Have a great evening.
Q2 14' Sticky - Key take aways and updated 'LIST' -
Q3 14' expected mid November
Post by:Ronald Redfield
My updated notes on Tweed $TWMJF $TWDhttp://t.co/VXulj7oNmM Shares o/s 40M. Current prices $2.50 (TWD not TWMJF), market cap is < $100M.
— Ronald Redfield (@rbco) August 28, 2014
It's always difficult to hold on to shares when you keep seeing red. Especially when it doesn't seem to be the companies at fault.
Yes, one person came on here to share a negative experience.
We have others who are Tweed customers who have shares positive experiences.
Try to stay away from the noise. If you're concerned please contact investor relations like I do. Put time and effort into your investment.
If you don't like what you see, sell. End of story.
I for one have continued to share my view of why we are going down.
Two big factors: Overall market weakness and MJ sector weakness.
Something else to ask about in Q3 conference call. I will also contact investor relations to see if I can more information. I should also email Marc to see if he can give me more information.
The tone and grammar seems awfully familiar with this person doesn't it?
When you break down the names into two parts you can get AwesomeTweed which has 3 syllables. Half Life 3 confirmed.
Is that what your crystal ball is showing? If it happens I would like to order one of your crystal balls.
There is no one specific reason why it's fallen. Look through past posts here from the regulars. We have all stated reasons why it seems to have fallen.
*TSX / Russell corrections
*MJ Sector as a whole has continued to get beaten.
ext ext ext, nothing specific to do with Tweed or someone of these other more legit companies at a fundamental level.
Nice observation, let's see if the techs hold in the next few months.
I'm of the opinion that the "market makers" are getting prepped for a cyclical run. I have no proof other than what I'm seeing here. If I'm correct we should see the beginning of an up trend in the sector sometime in Oct.
Here's to crossing our fingers.
Thank you for the sharing the DD.
Welp got my 2k more shares filled with all this downward volume.
You, I, and a handful of others see this and how terrible the sector and market are. Yet the blame falls on the company when there is evidence that it should be the contrary. =)
Markets correct, sectors flourish/crash, all part of the game.
Tweed and the MJ sector will have its time.
I regret that your impression is one of a being "touchy".
I have performed my DD and spoken to Tweed investor relations and support staff in the past. They have always been helpful and timely. I invite you to please share your grievances with Tweed personnel and if you would be so kind, please post here replies and the outcome.
They aren't doing anything wrong that I can see. Look at the volume that tells the whole story. Yes, the chart sees a down trend. If volume stays the same then it trend will continue. The best way Tweed can serve it's investors is to continue to move forward. They do all they say they will do in a timely and efficient manner, that's what matters to me right now.
You should be sending this to investor relations.
I'm not sure who on this board thinks patients are "pot heads" but that shouldn't matter. People have opinions, some will be in line with your own, some not. Getting angry about it serves no purpose.
With respect, I'm skeptical of a person who says they are a patient and creates an account and posts just to trash the company. Seems such effort could be used more constructively. I hate Comcast as a company but I don't go on a stock board to complain about them. I use such effort to write to investor relations and the executive board, that's how things get resolved in a constructive manner.
They do so in such great precision. Love watching the growth.
My TWMJF order never filled at 2.05 which I put in at 9:20am. Even though it closed at 2.03. Let's see how it plays out tomorrow.
http://www.financialdirector.co.uk/financial-director/extraordinary-items-blog/2373065/rificis-high-hopes-as-cfo
The more I read the more I think he left to protect himself and Tweed from accusations of conflict of interest. His future is political. Linda McMahon from WWE did this prior to running for Senate.
Good. Today was a rough day for my account. Days like these I need to run an extra mile, lol.
Yeah, such pathetic volume will also draw the PPS down easily.
TWMJF is over double the avg volume right now. I have an order at 2.05 since 9:20am waiting to get filled, looks like buying is taking a while.
TWMJF also accounts for about 30k of todays volume. Some U.S. attention it seems.
I've been following the MJ stocks in general looking for some signals of accumulation for a Nov-Jan run. I think some people are prepping for such a run. That doesn't mean it's a guarantee though; it just means some people might have the same opinion that another run will be happening soon.
Yeah that would make sense. Considering we had a month of selling with limited supply last Q. 200-300% should be doable. Hopefully this IR firm Tweed hired will do a good job with the information.
Not surprised, I actually expect prices as a whole to go up. They are well below black market prices and these companies need to get into profitability zone sooner rather than later.
We could always ask why it is they seem to have issue keeping stock of certain strains. It could be harder to grow or they miscalculated demand.
Put in my order for 2000k more shares. Let's see if I hit it this time. If not, no prob. We are in a long lul period. A whole lot of uncertainties with the sector and the market as a whole. Do we get another sector bull run end of year? We will see.